111 related articles for article (PubMed ID: 7914057)
1. Systemic hyperthermia in the treatment of HIV-related disseminated Kaposi's sarcoma. Long-term follow-up of patients treated with low-flow extracorporeal perfusion hyperthermia.
Alonso K; Pontiggia P; Sabato A; Calvi G; Curto FC; de Bartolomei E; Nardi C; Cereda P
Am J Clin Oncol; 1994 Aug; 17(4):353-9. PubMed ID: 7914057
[TBL] [Abstract][Full Text] [Related]
2. Systemic hyperthermia in the treatment of HIV-related Kaposi's sarcoma. A phase I study.
Alonso K; Pontiggia P; Nardi C; Sabato A; Cuppone Curto F
Biomed Pharmacother; 1992; 46(1):21-4. PubMed ID: 1358242
[TBL] [Abstract][Full Text] [Related]
3. Total body hyperthermia in the treatment of Kaposi's sarcoma in an HIV positive patient.
Logan WD; Alonso K
Med Oncol Tumor Pharmacother; 1991; 8(1):45-7. PubMed ID: 2041382
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma: a reevaluation.
Orfanos CE; Husak R; Wölfer U; Garbe C
Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
[TBL] [Abstract][Full Text] [Related]
5. Effect of whole-body hyperthermia on AIDS patients with Kaposi's sarcoma: a pilot study.
Steinhart CR; Ash SR; Gingrich C; Sapir D; Keeling GN; Yatvin MB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Mar; 11(3):271-81. PubMed ID: 8603263
[TBL] [Abstract][Full Text] [Related]
6. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
[TBL] [Abstract][Full Text] [Related]
7. Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma.
Lane HC; Kovacs JA; Feinberg J; Herpin B; Davey V; Walker R; Deyton L; Metcalf JA; Baseler M; Salzman N
Lancet; 1988 Nov; 2(8622):1218-22. PubMed ID: 2903954
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's-sarcoma-associated herpesvirus is detected in peripheral blood mononuclear cells of HIV-infected homosexuals more often than in heterosexuals.
Rizzieri DA; Liu J; Miralles D; Traweek ST
Cancer J Sci Am; 1997; 3(3):153-6. PubMed ID: 9161780
[TBL] [Abstract][Full Text] [Related]
9. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of intercellular adhesion molecule 1 in patients with HIV-related Kaposi's sarcoma.
De Paoli P; Caffau C; D'Andrea M; Tavio M; Tirelli U; Santini G
J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):695-9. PubMed ID: 7911526
[TBL] [Abstract][Full Text] [Related]
11. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
[TBL] [Abstract][Full Text] [Related]
12. Lack of antitumor activity and intolerance of interleukin-4 in patients with advanced HIV disease and Kaposi's sarcoma.
Miles SA; Testa M; Huang J; Wade M; Carden J; Scadden DT
J Interferon Cytokine Res; 2002 Nov; 22(11):1143-8. PubMed ID: 12513914
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma.
Baumann R; Täuber MG; Opravil M; Hirschel B; Kinloch S; Chave JP; Pletscher M; Lüthy R
Klin Wochenschr; 1991 May; 69(8):360-7. PubMed ID: 1909399
[TBL] [Abstract][Full Text] [Related]
14. Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. The Danish Study Group for HIV Infection (DASHI).
Lundgren JD; Melbye M; Pedersen C; Rosenberg PS; Gerstoft J
Am J Epidemiol; 1995 Apr; 141(7):652-8. PubMed ID: 7702040
[TBL] [Abstract][Full Text] [Related]
15. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal whole body hyperthermia treatments for HIV infection and AIDS.
Ash SR; Steinhart CR; Curfman MF; Gingrich CH; Sapir DA; Ash EL; Fausset JM; Yatvin MB
ASAIO J; 1997; 43(5):M830-8. PubMed ID: 9360163
[TBL] [Abstract][Full Text] [Related]
17. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
Min J; Katzenstein DA
AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
[TBL] [Abstract][Full Text] [Related]
18. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era.
Mowatt L
West Indian Med J; 2013; 62(4):305-12. PubMed ID: 24756590
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
Lebbé C; Blum L; Pellet C; Blanchard G; Vérola O; Morel P; Danne O; Calvo F
AIDS; 1998 May; 12(7):F45-9. PubMed ID: 9619797
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma.
Miles SA; Dezube BJ; Lee JY; Krown SE; Fletcher MA; Saville MW; Kaplan L; Groopman J; Scadden DT; Cooley T; Von Roenn J; Friedman-Kien A;
AIDS; 2002 Feb; 16(3):421-9. PubMed ID: 11834954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
